e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Biology and diagnosis of thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How do lung cancer patients die?
A. Narayanaswamy, M. Thirumaran, K. Lilley, D. Saralaya, B. Jacob (Bradford, United Kingdom)
Source:
Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Session:
Biology and diagnosis of thoracic tumours
Session type:
E-Communication Session
Number:
4702
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Narayanaswamy, M. Thirumaran, K. Lilley, D. Saralaya, B. Jacob (Bradford, United Kingdom). How do lung cancer patients die?. Eur Respir J 2008; 32: Suppl. 52, 4702
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Who should treat lung cancer patients and where should they be treated?
Source: Annual Congress 2009 - Fitness for radical therapy in lung cancer patients
Year: 2009
Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening?
Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018
Year: 2018
Why can initial treatment of localised lung cancer fail?
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007
Stage I lung cancer patients with or without symptoms – are the patients any different?
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
What is real prevalence of COPD in patients with lung cancer?
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
First hospitalization in lung cancer patients – is timing important?
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021
Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007
Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009
How to treat lung cancer in IPF patients
Source: Research Seminar 2015
Year: 2015
Surgery for elderly early-stage non-small cell lung cancer: less or more?
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019
Causes of death in patients operated for lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 173s
Year: 2005
Causes of hospitalization in patients with lung cancer
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017
VATS in lung cancer treatment: for which patients?
Source: International Congress 2014 – An update on video-assisted thoracic surgery (VATS) in pleuropulmonary diseases
Year: 2014
Do cavitating non-small cell lung cancer patients have a more aggressive disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006
The delays due to patient‘s and doctors‘ in non- small cell lung cancer patients
Source: Annual Congress 2003 - Lung cancer management and prognosis
Year: 2003
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept